Jack W. Singer
2014
In 2014, Jack W. Singer earned a total compensation of $2.1M as Executive Vice President, Chief Scientific Officer, Interim Chief Medical Officer and Global Head of Translational Medicine at CTI BioPharma, a 57% increase compared to previous year.
Compensation breakdown
| Bonus | $175,750 |
|---|---|
| Salary | $370,000 |
| Stock Awards | $1,542,615 |
| Other | $55,234 |
| Total | $2,143,599 |
Singer received $1.5M in stock awards, accounting for 72% of the total pay in 2014.
Singer also received $175.8K in bonus, $370K in salary and $55.2K in other compensation.
Rankings
In 2014, Jack W. Singer's compensation ranked 4,232nd out of 13,032 executives tracked by ExecPay. In other words, Singer earned more than 67.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,232 out of 13,032 | 68th |
Division Manufacturing | 1,496 out of 4,965 | 70th |
Major group Chemicals And Allied Products | 490 out of 1,690 | 71st |
Industry group Drugs | 379 out of 1,369 | 72nd |
Industry Pharmaceutical Preparations | 302 out of 1,042 | 71st |
Source: SEC filing on March 28, 2017.
Singer's colleagues
We found three more compensation records of executives who worked with Jack W. Singer at CTI BioPharma in 2014.